Quantum Healthcare Statistics

Total Valuation

SGXC:V8Y has a market cap or net worth of SGD 8.01 million. The enterprise value is 15.59 million.

Market Cap	8.01M
Enterprise Value	15.59M

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

SGXC:V8Y has 8.01 billion shares outstanding. The number of shares has increased by 8.46% in one year.

Current Share Class	8.01B
Shares Outstanding	8.01B
Shares Change (YoY)	+8.46%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	70.34%
Owned by Institutions (%)	0.42%
Float	2.38B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.63
PB Ratio	-2.69
P/TBV Ratio	n/a
P/FCF Ratio	7.32
P/OCF Ratio	5.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.33, with an EV/FCF ratio of 14.23.

EV / Earnings	-6.98
EV / Sales	1.23
EV / EBITDA	23.33
EV / EBIT	n/a
EV / FCF	14.23

Financial Position

The company has a current ratio of 0.28

Current Ratio	0.28
Quick Ratio	0.27
Debt / Equity	n/a
Debt / EBITDA	11.44
Debt / FCF	6.98
Interest Coverage	-2.34

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.26%
Return on Invested Capital (ROIC)	-16.49%
Return on Capital Employed (ROCE)	-98.62%
Revenue Per Employee	145,805
Profits Per Employee	-25,678
Employee Count	87
Asset Turnover	0.99
Inventory Turnover	167.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.65, so SGXC:V8Y's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-50.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	45.62
Average Volume (20 Days)	585,940

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:V8Y had revenue of SGD 12.69 million and -2.23 million in losses. Loss per share was -0.00.

Revenue	12.69M
Gross Profit	5.66M
Operating Income	-1.08M
Pretax Income	-2.52M
Net Income	-2.23M
EBITDA	-556,000
EBIT	-1.08M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 714,000 in cash and 7.65 million in debt, giving a net cash position of -6.93 million or -0.00 per share.

Cash & Cash Equivalents	714,000
Total Debt	7.65M
Net Cash	-6.93M
Net Cash Per Share	-0.00
Equity (Book Value)	-2.98M
Book Value Per Share	-0.00
Working Capital	-8.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.45 million and capital expenditures -353,000, giving a free cash flow of 1.10 million.

Operating Cash Flow	1.45M
Capital Expenditures	-353,000
Free Cash Flow	1.10M
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 44.60%, with operating and profit margins of -8.47% and -17.61%.

Gross Margin	44.60%
Operating Margin	-8.47%
Pretax Margin	-19.87%
Profit Margin	-17.61%
EBITDA Margin	-4.38%
EBIT Margin	-8.47%
FCF Margin	8.63%

Dividends & Yields

SGXC:V8Y does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.46%
Shareholder Yield	-8.46%
Earnings Yield	-27.87%
FCF Yield	13.66%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:V8Y has an Altman Z-Score of -27.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-27.52
Piotroski F-Score	n/a